Serologic testing is the most convenient approach for diagnosing histoplasmosis. The complement fixation (CF) test for histoplasmal (histo) antibodies (Abs), which was performed in a standard microtitration system (2) with yeast and mycelial antigens, provides excellent specificity and is more sensitive than the immunodiffusion test (3 (Tables 1 and 2) were collected from 41 patients whose histoplasmosis was confirmed in our laboratory by culture or by positive histo urine antigen radioimmunoassay (4) In order to avoid problems such as those described in this report, it is essential for clinical laboratories to follow a comprehensive quality assurance program. We recommend the testing of each new lot of histo antigen against a panel of human sera known to contain histo yeast and mycelial Abs. Also, old and new antigen products should be tested in parallel when a change in manufacturer or in the manufacturing process of a reagent is made.
Other serologic test antigens that are marketed with positive control sera from animals are potential candidates for similar difficulties. It is essential that known human control sera be obtained and tested periodically. Manufacturers should be encouraged to test their antigens against known positive and negative human sera and to market human control sera with their antigens, if it is possible to do so.
We thank Shirley Collins and Sandra English for assisting with histo Ab CF testing, Judy Stacey for preparing the manuscript, and CDC for providing reference histo antigens and antisera.
